Literature DB >> 21452739

Sensitivity of postplanning target and OAR coverage estimates to dosimetric margin distribution sampling parameters.

Huijun Xu1, J James Gordon, Jeffrey V Siebers.   

Abstract

PURPOSE: A dosimetric margin (DM) is the margin in a specified direction between a structure and a specified isodose surface, corresponding to a prescription or tolerance dose. The dosimetric margin distribution (DMD) is the distribution of DMs over all directions. Given a geometric uncertainty model, representing inter- or intrafraction setup uncertainties or internal organ motion, the DMD can be used to calculate coverage Q, which is the probability that a realized target or organ-at-risk (OAR) dose metric D, exceeds the corresponding prescription or tolerance dose. Postplanning coverage evaluation quantifies the percentage of uncertainties for which target and OAR structures meet their intended dose constraints. The goal of the present work is to evaluate coverage probabilities for 28 prostate treatment plans to determine DMD sampling parameters that ensure adequate accuracy for postplanning coverage estimates.
METHODS: Normally distributed interfraction setup uncertainties were applied to 28 plans for localized prostate cancer, with prescribed dose of 79.2 Gy and 10 mm clinical target volume to planning target volume (CTV-to-PTV) margins. Using angular or isotropic sampling techniques, dosimetric margins were determined for the CTV, bladder and rectum, assuming shift invariance of the dose distribution. For angular sampling, DMDs were sampled at fixed angular intervals w (e.g., w = 1 degree, 2 degrees, 5 degrees, 10 degrees, 20 degrees). Isotropic samples were uniformly distributed on the unit sphere resulting in variable angular increments, but were calculated for the same number of sampling directions as angular DMDs, and accordingly characterized by the effective angular increment omega eff. In each direction, the DM was calculated by moving the structure in radial steps of size delta (=0.1, 0.2, 0.5, 1 mm) until the specified isodose was crossed. Coverage estimation accuracy deltaQ was quantified as a function of the sampling parameters omega or omega eff and delta.
RESULTS: The accuracy of coverage estimates depends on angular and radial DMD sampling parameters omega or omega eff and delta, as well as the employed sampling technique. Target deltaQ/ < l% and OAR /deltaQ/ < 3% can be achieved with sampling parameters omega or omega eef = 20 degrees, delta =1 mm. Better accuracy (target /deltaQ < 0.5% and OAR /deltaQ < approximately 1%) can be achieved with omega or omega eff = 10 degrees, delta = 0.5 mm. As the number of sampling points decreases, the isotropic sampling method maintains better accuracy than fixed angular sampling.
CONCLUSIONS: Coverage estimates for post-planning evaluation are essential since coverage values of targets and OARs often differ from the values implied by the static margin-based plans. Finer sampling of the DMD enables more accurate assessment of the effect of geometric uncertainties on coverage estimates prior to treatment. DMD sampling with omega or omega eff = 10 degrees and delta = 0.5 mm should be adequate for planning purposes.

Entities:  

Mesh:

Year:  2011        PMID: 21452739      PMCID: PMC3045415          DOI: 10.1118/1.3544364

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.

Authors:  J C Stroom; H C de Boer; H Huizenga; A G Visser
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

2.  The effect of set-up uncertainties, contour changes, and tissue inhomogeneities on target dose-volume histograms.

Authors:  B C John Cho; Marcel van Herk; Ben J Mijnheer; Harry Bartelink
Journal:  Med Phys       Date:  2002-10       Impact factor: 4.071

3.  Biologic and physical fractionation effects of random geometric errors.

Authors:  Marcel van Herk; Marnix Witte; Joris van der Geer; Christoph Schneider; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

4.  Geometric uncertainties in radiotherapy.

Authors:  J M Wilkinson
Journal:  Br J Radiol       Date:  2004-02       Impact factor: 3.039

5.  Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans.

Authors:  J J Gordon; A J Crimaldi; M Hagan; J Moore; J V Siebers
Journal:  Med Phys       Date:  2007-01       Impact factor: 4.071

6.  Dosimetric impact of image-guided 3D conformal radiation therapy of prostate cancer.

Authors:  B Schaly; G S Bauman; W Song; J J Battista; J Van Dyk
Journal:  Phys Med Biol       Date:  2005-06-22       Impact factor: 3.609

7.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

8.  Observations on real-time prostate gland motion using electromagnetic tracking.

Authors:  Katja M Langen; Twyla R Willoughby; Sanford L Meeks; Anand Santhanam; Alexis Cunningham; Lisa Levine; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-14       Impact factor: 7.038

9.  Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.

Authors:  Michael R Button; Carys A Morgan; Elizabeth S Croydon; S Ashley Roberts; Thomas D L Crosby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-19       Impact factor: 7.038

10.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?

Authors:  L Ekberg; O Holmberg; L Wittgren; G Bjelkengren; T Landberg
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280

View more
  2 in total

1.  Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment.

Authors:  Huijun Xu; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

2.  Coverage-based treatment planning to accommodate deformable organ variations in prostate cancer treatment.

Authors:  Huijun Xu; Douglas J Vile; Manju Sharma; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2014-10       Impact factor: 4.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.